Citation: | Zhang Qianqian, Xie Yalong, Wang Feng, et al. Value of dynamic monitoring of absolute value and function of peripheral blood lymphocyte subsets in predicting the risk of early viral infection after kidney transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(1): 80-87. doi: 10.3969/j.issn.1674-7445.2022.01.013 |
[1] |
SHIPKOVA M, WIELAND E. Editorial: immune monitoring in solid organ transplantation[J]. Clin Biochem, 2016, 49(4/5): 317-319. DOI: 10.1016/j.clinbiochem.2016.01.005.
|
[2] |
YU M, LIU M, ZHANG W, et al. Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation[J]. Curr Drug Metab, 2018, 19(6): 513-522. DOI: 10.2174/1389200219666180129151948.
|
[3] |
ZHUANG Q, PENG B, WEI W, et al. The detailed distribution of T cell subpopulations in immune-stable renal allograft recipients: a single center study[J]. PeerJ, 2019, 7: e6417. DOI: 10.7717/peerj.6417.
|
[4] |
CHAE MS, KIM JW, CHUNG HS, et al. The impact of serum cytokines in the development of early allograft dysfunction in living donor liver transplantation[J]. Medicine (Baltimore), 2018, 97(16): e0400. DOI: 10.1097/MD.0000000000010400.
|
[5] |
MARGETA I, MAREKOVIĆ I, PEŠUT A, et al. Evaluation of cell-mediated immune response by quantiFERON monitor assay in kidney transplant recipients presenting with infective complications[J]. Medicine (Baltimore), 2020, 99(27): e21010. DOI: 10.1097/MD.0000000000021010.
|
[6] |
LEE DM, ABECASSIS MM, FRIEDEWALD JJ, et al. Kidney graft surveillance biopsy utilization and trends: results from a survey of high-volume transplant centers[J]. Transplant Proc, 2020, 52(10): 3085-3089. DOI: 10.1016/j.transproceed.2020.04.1816.
|
[7] |
PLATTNER BW, CHEN P, CROSS R, et al. Complications and adequacy of transplant kidney biopsies: a comparison of techniques[J]. J Vasc Access, 2018, 19(3): 291-296. DOI: 10.1177/1129729817747543.
|
[8] |
ALSPACH E, LUSSIER DM, SCHREIBER RD. Interferon γ and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity[J]. Cold Spring Harb Perspect Biol, 2019, 11(3): a028480. DOI: 10.1101/cshperspect.a028480.
|
[9] |
FARHOOD B, NAJAFI M, MORTEZAEE K. CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review[J]. J Cell Physiol, 2019, 234(6): 8509-8521. DOI: 10.1002/jcp.27782.
|
[10] |
SHIU KY, MCLAUGHLIN L, REBOLLO-MESA I, et al. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells[J]. Kidney Int, 2017, 91(2): 477-492. DOI: 10.1016/j.kint.2016.10.009.
|
[11] |
CRESPO E, CRAVEDI P, MARTORELL J, et al. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients[J]. Kidney Int, 2017, 92(1): 201-213. DOI: 10.1016/j.kint.2016.12.024.
|
[12] |
KIM T, LEE HJ, KIM SM, et al. Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant[J]. Korean J Intern Med, 2020, 35(2): 438-448. DOI: 10.3904/kjim.2017.318.
|
[13] |
KRISNAWATI DI, LIU YC, LEE YJ, et al. Blockade effects of anti-interferon- (IFN-) γ autoantibodies on IFN-γ-regulated antimicrobial immunity[J]. J Immunol Res, 2019: 1629258. DOI: 10.1155/2019/1629258.
|
[14] |
HOU H, ZHOU Y, YU J, et al. Establishment of the reference intervals of lymphocyte function in healthy adults based on IFN-γ secretion assay upon phorbol-12-myristate-13-acetate/ionomycin stimulation[J]. Front Immunol, 2018, 9: 172. DOI: 10.3389/fimmu.2018.00172.
|
[15] |
LUO Y, XIE Y, ZHANG W, et al. Combination of lymphocyte number and function in evaluating host immunity[J]. Aging (Albany NY), 2019, 11(24): 12685-12707. DOI: 10.18632/aging.102595.
|
[16] |
WIEBE C, KOSMOLIAPTSIS V, POCHINCO D, et al. HLA-DR/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity[J]. Am J Transplant, 2019, 19(6): 1708-1719. DOI: 10.1111/ajt.15177.
|
[17] |
ISRAELI M, KLEIN T, BRANDHORST G, et al. Confronting the challenge: individualized immune monitoring after organ transplantation using the cellular immune function assay[J]. Clin Chim Acta, 2012, 413(17/18): 1374-1378. DOI: 10.1016/j.cca.2012.01.033.
|
[18] |
REZAHOSSEINI O, MØLLER DL, KNUDSEN AD, et al. Use of T cell mediated immune functional assays for adjustment of immunosuppressive or anti-infective agents in solid organ transplant recipients: a systematic review[J]. Front Immunol, 2020, 11: 567715. DOI: 10.3389/fimmu.2020.567715.
|
[19] |
HARTMANN FJ, BABDOR J, GHERARDINI PF, et al. Comprehensive immune monitoring of clinical trials to advance human immunotherapy[J]. Cell Rep, 2019, 28(3): 819-831. DOI: 10.1016/j.celrep.2019.06.049.
|
[20] |
PENG B, GONG H, TIAN H, et al. The study of the association between immune monitoring and pneumonia in kidney transplant recipients through machine learning models[J]. J Transl Med, 2020, 18(1): 370. DOI: 10.1186/s12967-020-02542-2.
|
[21] |
UDOMKARNJANANUN S, KERR SJ, TOWNAMCHAI N, et al. Donor-specific ELISPOT assay for predicting acute rejection and allograft function after kidney transplantation: a systematic review and Meta-analysis[J]. Clin Biochem, 2021, 94: 1-11. DOI: 10.1016/j.clinbiochem.2021.04.011.
|
[22] |
毛天赐, 田普训, 薛武军, 等. 分泌干扰素-γ的效应T细胞在预警肾移植术后急性排斥反应中的意义[J]. 器官移植, 2013, 4(6): 325-330. DOI: 10.3969/j.issn.1674-7445.2013.06.004.
MAO TC, TIAN PX, XUE WJ, et al. Significance of effector T cell secreting interferon-γ on early warning of acute rejection after renal transplantation[J]. Organ Transplant, 2013, 4(6): 325-330. DOI: 10.3969/j.issn.1674-7445.2013.06.004.
|
[23] |
SALDAN A, FORNER G, MENGOLI C, et al. Comparison of the cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiFERON cell-mediated immune assays in CMV-seropositive and -seronegative pregnant and nonpregnant women[J]. J Clin Microbiol, 2016, 54(5): 1352-1356. DOI: 10.1128/JCM.03128-15.
|
[24] |
ATLANI M, SHARMA RK, GUPTA A. Basiliximab induction in renal transplantation: long-term outcome[J]. Saudi J Kidney Dis Transpl, 2013, 24(3): 473-479. DOI: 10.4103/1319-2442.111010.
|
[25] |
HOU X, LU C, CHEN S, et al. High throughput sequencing of T cell antigen receptors reveals a conserved TCR repertoire[J]. Medicine (Baltimore), 2016, 95(10): e2839. DOI: 10.1097/MD.0000000000002839.
|
[26] |
GILL RG, BURRACK AL. Diverse routes of allograft tolerance disruption by memory T cells[J]. Front Immunol, 2020, 11: 580483. DOI: 10.3389/fimmu.2020.580483.
|
[27] |
LEE SJ, KIM HJ, BYUN NR, et al. Donor-specific regulatory T cell-mediated immune tolerance in an intrahepatic murine allogeneic islet transplantation model with short-term anti-CD154 mAb single treatment[J]. Cell Transplant, 2020, 29: 963689720913876. DOI: 10.1177/0963689720913876.
|
[28] |
PATHAK S, MEYER EH. Tregs and mixed chimerism as approaches for tolerance induction in islet transplantation[J]. Front Immunol, 2021, 11: 612737. DOI: 10.3389/fimmu.2020.612737.
|
[29] |
HIGDON LE, TROFE-CLARK J, LIU S, et al. Cytomegalovirus-responsive CD8+ T cells expand after solid organ transplantation in the absence of CMV disease[J]. Am J Transplant, 2017, 17(8): 2045-2054. DOI: 10.1111/ajt.14227.
|
[30] |
BETJES MGH, LANGERAK AW, KLEPPER M, et al. A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation[J]. Immun Ageing, 2020, 17: 4. DOI: 10.1186/s12979-020-00175-z.
|
[31] |
CHEN D, ZHAO R, CAO W, et al. Clinical characteristics of cytomegalovirus gastritis: a retrospective study from a tertiary medical center[J]. Medicine (Baltimore), 2020, 99(5): e18927. DOI: 10.1097/MD.0000000000018927.
|
[32] |
FERREIRA VH, KUMAR D, HUMAR A. Deep profiling of the CD8+ T-cell compartment identifies activated cell subsets and multifunctional responses associated with control of cytomegalovirus viremia[J]. Transplantation, 2019, 103(3): 613-621. DOI: 10.1097/TP.0000000000002373.
|
[33] |
DENDLE C, MULLEY WR, HOLDSWORTH S. Can immune biomarkers predict infections in solid organ transplant recipients? a review of current evidence[J]. Transplant Rev (Orlando), 2019, 33(2): 87-98. DOI: 10.1016/j.trre.2018.10.001.
|
[34] |
DRABE CH, SØRENSEN SS, RASMUSSEN A, et al. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo: SOT study): a prospective non-interventional observational trial[J]. BMC Infect Dis, 2019, 19(1): 573. DOI: 10.1186/s12879-019-4207-9.
|